Related Experiment Video
Updated: Jul 23, 2025
05:41
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
666
Nanomaterials: a promising multimodal theranostics platform for thyroid cancer
1State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China. linquan@jlu.edu.cn.
Journal of Materials Chemistry. B
|July 13, 2023
Summary
Nanomedicine offers advanced solutions for thyroid cancer, improving diagnosis via multimodal imaging and enabling targeted treatments like photothermal therapy. This approach promises better patient outcomes and addresses unmet needs in aggressive thyroid cancer cases.
Area of Science:
- Oncology
- Nanomedicine
- Biomedical Engineering
Background:
- Thyroid cancer incidence is rising, with current diagnostic methods like ultrasound-guided fine needle aspiration having limitations.
- Differentiated thyroid carcinoma has a good prognosis, but dedifferentiation leads to poor outcomes.
- Anaplastic thyroid cancer is highly aggressive and lacks effective treatments.
Purpose of the Study:
- To review the latest advancements in nanomaterials for thyroid cancer diagnosis and treatment.
- To explore the potential of nanomedicine in improving thyroid cancer theranostics.
- To encourage research into innovative nanotheranostic approaches for thyroid cancer.
Main Methods:
- Review of current literature on nanomaterials in thyroid cancer.
- Analysis of nanomaterial applications in multimodal imaging for diagnosis.
- Evaluation of nanomaterial-based therapeutic strategies including photothermal therapy, photodynamic therapy, chemotherapy, radiotherapy, and gene therapy.
Main Results:
- Nanomaterials facilitate non-invasive, multimodal imaging for enhanced thyroid cancer diagnosis.
- Nanoparticle-based therapies (photothermal, photodynamic) combined with conventional treatments show promise for reducing invasiveness and improving survival.
- Nanomaterials offer potential for simultaneous diagnosis and treatment (theranostics) of thyroid cancer.
Conclusions:
- Nanomedicine presents a promising frontier for thyroid cancer theranostics, addressing limitations of current methods.
- Multifunctional nanomaterials can significantly improve diagnostic accuracy and therapeutic efficacy.
- Further research is crucial to develop and translate these innovative nanotheranostic approaches into clinical practice for better thyroid cancer management.
